Zinaida Good

Title: Zinaida Good: Innovator in T Cell Therapy

Introduction

Zinaida Good is a prominent inventor based in Stanford, CA (US). She has made significant contributions to the field of immunotherapy, particularly in the expansion of T cell populations for cancer treatment. Her innovative work has the potential to enhance the effectiveness of adoptive cell therapies.

Latest Patents

Zinaida Good holds a patent for "Compositions and methods of expansion of T cell populations." This patent relates to compositions and methods that are useful for adoptive cell therapy. The disclosure includes methods for producing a population of lymphocytes enriched in T stem cell memory cells (T cells). Additionally, it provides compositions containing a substantially pure population of T cells that are therapeutically effective in treating various cancers. The patent also outlines methods for treating subjects with cancer using the disclosed compositions and kits.

Career Highlights

Zinaida Good is affiliated with Leland Stanford Junior University, where she conducts her research and development in the field of cancer therapies. Her work is instrumental in advancing the understanding and application of T cell therapies in clinical settings.

Collaborations

Zinaida collaborates with notable colleagues, including Garry P Nolan and Sean Bendall. Their combined expertise contributes to the innovative research being conducted at Stanford.

Conclusion

Zinaida Good is a trailblazer in the field of T cell therapy, with her patent and research paving the way for new cancer treatment methodologies. Her contributions are vital to the ongoing advancements in immunotherapy.